Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Cigna profit misses Wall Street target

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 07:05am EST

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Insurer Cigna Corp (>> CIGNA Corporation) posted a lower-than-expected first-quarter profit on Thursday, as earnings slipped in its segment offering disability and life coverage policies.

Cigna is the latest health insurer to miss Wall Street's earnings target in the period, following Aetna Inc (>> Aetna Inc.), Coventry Health Care (>> Coventry Health Care, Inc.) and Humana Inc (>> Humana Inc.).

Cigna did raise its full-year earnings forecast.

Net income fell to $371 million, or $1.28 per share, from $413 million, or $1.51 per share, a year earlier.

Excluding special items, Cigna's earnings of $1.28 per share fell 2 cents below the analysts' average estimate, according to Thomson Reuters I/B/E/S.

Revenue jumped 25 percent to $6.79 billion, helped by the acquisition of Medicare specialist HealthSpring.

Profit in the main healthcare segment rose 6.5 percent to $262 million, helped by rising membership in its plans.

But earnings in its disability and life segment fell 16 percent to $65 million. The company cited strategic investments in its disability management programs as a factor pushing down profit.

Cigna forecast 2012 earnings of $5.20 to $5.55 per share. It previously projected $5.00 to $5.40. Analysts have been looking for $5.41.

(Reporting by Lewis Krauskopf in New York; Editing by Lisa Von Ahn)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
12/05 CIGNA : Earns Top Marks in 2017 Corporate Equality Index for 5th Consecutive Yea..
11/30 CIGNA : Launches One Guide – Simplified, Personalized Service to Help Choo..
11/30 CIGNA : Launches One Guide - Simplified, Personalized Service to Help Choose Hea..
11/29DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/28DJANTHEM : Testimony Shows Anthem and Cigna at Odds Over Proposed Merger -- Update
11/28DJANTHEM : Testimony Shows Anthem and Cigna At Odds Over Proposed Merger
11/28 CIGNA : Offers Holiday Survival Tips as Part of National Health Improvement Tour
11/28 CIGNA CORPORATION (NYSE : CI) Files An 8-K Regulation FD Disclosure
11/28 CIGNA CORP : Regulation FD Disclosure (form 8-K)
11/24 CIGNA : Firefly Value Partners Lp buys $13,500,670 stake in CIGNA Corporation
More news
Sector news : Managed Healthcare - NEC
12/05DJAetna and Humana Argue a Merger's Benefits as Antitrust Trial Begins
11/29DJANTHEM : Begins Defense of Cigna Merger at Antitrust Trial
11/29DJU.S. Stocks Edge Higher
11/28DJANTHEM : Testimony Shows Anthem and Cigna at Odds Over Proposed Merger -- Update
11/28DJUNITEDHEALTH : Gives Upbeat Outlook for 2017
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
12/01 UnitedHealth Group's Free Cash Flow Generation Impresses
11/30 What A Hillary Recount Could Mean To You
11/28 Cigna sees non-GAAP operating income of almost $2.1B this year
11/27 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2016 Updat..
11/25 Black Friday (Arb) Bargains
Advertisement
Financials ($)
Sales 2016 39 579 M
EBIT 2016 3 297 M
Net income 2016 1 936 M
Debt 2016 1 292 M
Yield 2016 0,02%
P/E ratio 2016 18,38
P/E ratio 2017 14,60
EV / Sales 2016 0,92x
EV / Sales 2017 0,88x
Capitalization 35 237 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 151 $
Spread / Average Target 9,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION-6.21%35 237
UNITEDHEALTH GROUP INC33.73%149 740
AETNA INC18.89%45 105
ANTHEM INC2.95%37 816
HUMANA INC14.45%30 461
CENTENE CORP-14.01%9 671
More Results